Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects

H. P. Kuo, T. R. Yu, C. T. Yu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The phenotypically distinct low-density eosinophil, with its greater inflammatory potential, is increased in asthma. However, the role of hypodense eosinophils in the development of asthma is still unclear. We conducted a double-blind, placebo-controlled study to examine the effect of inhaled corticosteroids on the number of hypodense eosinophils in 27 asthmatic subjects and its relationship with clinical severity. The density profile of eosinophils in the peripheral blood was determined using Percoll density gradient fractionation. Eosinophils recovered from asthmatics were mainly in the lower density fractions (<1.095 g · ml-1) (63 ± 3%; n = 27), significantly different from those of normal subjects (27 ± 2%; n = 7). The proportion of hypodense eosinophils was inversely related to the provocative concentration of methacholine producing a 20% fall in forced expiratory volume in one second (PC20) value (r = -0.75). Patients with mild asthma had a lower percentage of hypodense eosinophils (45 ± 4%; n = 14) than those with moderate asthma (67 ± 3%; n = 13). Inhalation of budesonide (800 μg · day-1) (n = 15) for 4 weeks, but not placebo, significantly improved the PC20 values by 0.97 doubling dose, forced expiratory volume in one second (FEV1) % predicted by 17%, and peak expiratory flow rate (PEFR) by 15%, and decreased PEFR diurnal variability by 5.4%. The percentage of hypodense eosinophils was significantly decreased from 68 ± 4 to 47 ± 4% in the budesonide group (n = 15), but not in the placebo group (n = 12) (63 ± 4 to 65 ± 4%). The percentage of lower density eosinophils (1.080-1.085 and 1.085-1.090 g · ml-1) significantly decreased in the budesonide group but not in the placebo group, with a concomitant increase in the highest density (1.095-1.100 g · ml-1). We conclude that hypodense eosinophils are closely related to clinical severity and airway hyperresponsiveness. The clinical efficacy of corticosteroids might be mediated by inhibiting the conversion of eosinophils into hypodense subpopulations.

Original languageEnglish
Pages (from-to)1452-1459
Number of pages8
JournalEuropean Respiratory Journal
Volume7
Issue number8
Publication statusPublished - Jan 1 1994
Externally publishedYes

Fingerprint

Eosinophils
Adrenal Cortex Hormones
Budesonide
Asthma
Placebos
Peak Expiratory Flow Rate
Forced Expiratory Volume
Methacholine Chloride
Inhalation

Keywords

  • Airway hyperresponsiveness
  • Airway inflammation
  • Bronchial asthma
  • Corticosteroid
  • Eosinophil
  • Fractionation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects. / Kuo, H. P.; Yu, T. R.; Yu, C. T.

In: European Respiratory Journal, Vol. 7, No. 8, 01.01.1994, p. 1452-1459.

Research output: Contribution to journalArticle

@article{9b9cbd0e88d146bba7079a51c85793a6,
title = "Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects",
abstract = "The phenotypically distinct low-density eosinophil, with its greater inflammatory potential, is increased in asthma. However, the role of hypodense eosinophils in the development of asthma is still unclear. We conducted a double-blind, placebo-controlled study to examine the effect of inhaled corticosteroids on the number of hypodense eosinophils in 27 asthmatic subjects and its relationship with clinical severity. The density profile of eosinophils in the peripheral blood was determined using Percoll density gradient fractionation. Eosinophils recovered from asthmatics were mainly in the lower density fractions (<1.095 g · ml-1) (63 ± 3{\%}; n = 27), significantly different from those of normal subjects (27 ± 2{\%}; n = 7). The proportion of hypodense eosinophils was inversely related to the provocative concentration of methacholine producing a 20{\%} fall in forced expiratory volume in one second (PC20) value (r = -0.75). Patients with mild asthma had a lower percentage of hypodense eosinophils (45 ± 4{\%}; n = 14) than those with moderate asthma (67 ± 3{\%}; n = 13). Inhalation of budesonide (800 μg · day-1) (n = 15) for 4 weeks, but not placebo, significantly improved the PC20 values by 0.97 doubling dose, forced expiratory volume in one second (FEV1) {\%} predicted by 17{\%}, and peak expiratory flow rate (PEFR) by 15{\%}, and decreased PEFR diurnal variability by 5.4{\%}. The percentage of hypodense eosinophils was significantly decreased from 68 ± 4 to 47 ± 4{\%} in the budesonide group (n = 15), but not in the placebo group (n = 12) (63 ± 4 to 65 ± 4{\%}). The percentage of lower density eosinophils (1.080-1.085 and 1.085-1.090 g · ml-1) significantly decreased in the budesonide group but not in the placebo group, with a concomitant increase in the highest density (1.095-1.100 g · ml-1). We conclude that hypodense eosinophils are closely related to clinical severity and airway hyperresponsiveness. The clinical efficacy of corticosteroids might be mediated by inhibiting the conversion of eosinophils into hypodense subpopulations.",
keywords = "Airway hyperresponsiveness, Airway inflammation, Bronchial asthma, Corticosteroid, Eosinophil, Fractionation",
author = "Kuo, {H. P.} and Yu, {T. R.} and Yu, {C. T.}",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "7",
pages = "1452--1459",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "8",

}

TY - JOUR

T1 - Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects

AU - Kuo, H. P.

AU - Yu, T. R.

AU - Yu, C. T.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The phenotypically distinct low-density eosinophil, with its greater inflammatory potential, is increased in asthma. However, the role of hypodense eosinophils in the development of asthma is still unclear. We conducted a double-blind, placebo-controlled study to examine the effect of inhaled corticosteroids on the number of hypodense eosinophils in 27 asthmatic subjects and its relationship with clinical severity. The density profile of eosinophils in the peripheral blood was determined using Percoll density gradient fractionation. Eosinophils recovered from asthmatics were mainly in the lower density fractions (<1.095 g · ml-1) (63 ± 3%; n = 27), significantly different from those of normal subjects (27 ± 2%; n = 7). The proportion of hypodense eosinophils was inversely related to the provocative concentration of methacholine producing a 20% fall in forced expiratory volume in one second (PC20) value (r = -0.75). Patients with mild asthma had a lower percentage of hypodense eosinophils (45 ± 4%; n = 14) than those with moderate asthma (67 ± 3%; n = 13). Inhalation of budesonide (800 μg · day-1) (n = 15) for 4 weeks, but not placebo, significantly improved the PC20 values by 0.97 doubling dose, forced expiratory volume in one second (FEV1) % predicted by 17%, and peak expiratory flow rate (PEFR) by 15%, and decreased PEFR diurnal variability by 5.4%. The percentage of hypodense eosinophils was significantly decreased from 68 ± 4 to 47 ± 4% in the budesonide group (n = 15), but not in the placebo group (n = 12) (63 ± 4 to 65 ± 4%). The percentage of lower density eosinophils (1.080-1.085 and 1.085-1.090 g · ml-1) significantly decreased in the budesonide group but not in the placebo group, with a concomitant increase in the highest density (1.095-1.100 g · ml-1). We conclude that hypodense eosinophils are closely related to clinical severity and airway hyperresponsiveness. The clinical efficacy of corticosteroids might be mediated by inhibiting the conversion of eosinophils into hypodense subpopulations.

AB - The phenotypically distinct low-density eosinophil, with its greater inflammatory potential, is increased in asthma. However, the role of hypodense eosinophils in the development of asthma is still unclear. We conducted a double-blind, placebo-controlled study to examine the effect of inhaled corticosteroids on the number of hypodense eosinophils in 27 asthmatic subjects and its relationship with clinical severity. The density profile of eosinophils in the peripheral blood was determined using Percoll density gradient fractionation. Eosinophils recovered from asthmatics were mainly in the lower density fractions (<1.095 g · ml-1) (63 ± 3%; n = 27), significantly different from those of normal subjects (27 ± 2%; n = 7). The proportion of hypodense eosinophils was inversely related to the provocative concentration of methacholine producing a 20% fall in forced expiratory volume in one second (PC20) value (r = -0.75). Patients with mild asthma had a lower percentage of hypodense eosinophils (45 ± 4%; n = 14) than those with moderate asthma (67 ± 3%; n = 13). Inhalation of budesonide (800 μg · day-1) (n = 15) for 4 weeks, but not placebo, significantly improved the PC20 values by 0.97 doubling dose, forced expiratory volume in one second (FEV1) % predicted by 17%, and peak expiratory flow rate (PEFR) by 15%, and decreased PEFR diurnal variability by 5.4%. The percentage of hypodense eosinophils was significantly decreased from 68 ± 4 to 47 ± 4% in the budesonide group (n = 15), but not in the placebo group (n = 12) (63 ± 4 to 65 ± 4%). The percentage of lower density eosinophils (1.080-1.085 and 1.085-1.090 g · ml-1) significantly decreased in the budesonide group but not in the placebo group, with a concomitant increase in the highest density (1.095-1.100 g · ml-1). We conclude that hypodense eosinophils are closely related to clinical severity and airway hyperresponsiveness. The clinical efficacy of corticosteroids might be mediated by inhibiting the conversion of eosinophils into hypodense subpopulations.

KW - Airway hyperresponsiveness

KW - Airway inflammation

KW - Bronchial asthma

KW - Corticosteroid

KW - Eosinophil

KW - Fractionation

UR - http://www.scopus.com/inward/record.url?scp=0027969111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027969111&partnerID=8YFLogxK

M3 - Article

C2 - 7957830

AN - SCOPUS:0027969111

VL - 7

SP - 1452

EP - 1459

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 8

ER -